The interstitial lung disease/rare lung disease program at Texas Children's Hospital consists of expert physicians, nursing, social work, and dieticians dedicated to the care of children with these complex and often severe diseases. We are one of the oldest ILD programs in the country and are recognized nationally and internationally as a top center for the care of ILD patients. We specialize in the care of interstitial lung disease, lung disease related to bone marrow transplant, and lung disease related to rheumatologic conditions. We have state-of-the-art diagnostic equipment as well as expertise in clinical care, radiology, pathology and, if needed, lung transplantation. We are active members in the Children’s Interstitial Lung Disease Research Network (chILDRN) and are affiliated with the Children’s Interstitial Lung Disease Foundation (chILD Foundation). Please visit the chILD Foundation website for more information.

Conditions treated:

Acute interstitial pneumonia/pneumonitis
Alveolar capillary dysplasia
Alveolar hemorrhage syndromes (pulmonary capillaritis, acute idiopathic pulmonary hemorrhage of infancy, and idiopathic pulmonary hemosiderosis)
Aspiration associated lung disease
Autoimmune or rheumatologic related lung disease
Bone marrow transplant associated lung disease/Graft versus host lung disease
Bronchiolitis obliterans
Cryptogenic organizing pneumonia formerly known as bronchiolitis obliterans organizing pneumonia (BOOP)
Desquamative interstitial pneumonia
DNA repair disorders
Drug induced lung disease
Eosinophilic pneumonias
Follicular bronchiolitis
Growth abnormalities
Hypersensitivity pneumonitis
Immune mediated lung disease
Immunocompromised host associated lung disease
Lymphocytic interstitial pneumonia
Lysosomal storage disorders
Neuroendocrine hyperplasia of infancy (NEHI)
Nonspecific interstitial pneumonia
Pulmonary alveolar proteinosis
Pulmonary interstitial glycogenosis (PIG)
Pulmonary alveolar microlithiasis
Pulmonary histiocytosis
Pulmonary lymphangiectasia
Pulmonary lymphangiomatosis (generalized lymphatic anomaly)
Pulmonary vascular disorders
Pulmonary sarcoidosis
Radiation induced lung disease
Surfactant gene mutation associated lung disease (SP-B, SP-C, ABCA3, TTF-1, GMCSF receptor)

Physicians:

Pulmonary: Timothy Vece, M.D.
Radiology: R. Paul Guillerman
Pathology: Norma Quintanilla